Therefore, based on the regulatory effect of TRPML1 on mTOR, the development of regulatory drugs targeting TRPML1 activity to achieve tumor suppression may provide greater specificity and better therapeutic effects than mTOR inhibitors. Here, MCOLN1 is linked to neoplasm.